Statements (103)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chronic_fatigue_syndrome
gptkb:multiple_sclerosis |
| gptkbp:advocacy |
government initiatives
research funding patient organizations |
| gptkbp:affects |
energy levels
quality of life both genders physical disabilities behavioral changes cognitive impairment seizure disorders |
| gptkbp:associated_with |
gptkb:Japanese_encephalitis_virus
gptkb:Epstein-Barr_virus gptkb:West_Nile_virus gptkb:HIV/_AIDS gptkb:Cytomegalovirus gptkb:Herpes_simplex_virus gptkb:multiple_sclerosis gptkb:cytomegalovirus gptkb:herpes_simplex_virus sleep disorders cardiovascular issues neurological disorders Lyme disease fibromyalgia autoimmune disorders sensory sensitivities gastrointestinal issues Enteroviruses metabolic dysfunction chronic viral infections chronic pain syndromes post-exertional malaise immune system abnormalities multiple chemical sensitivity orthostatic intolerance |
| gptkbp:case_definition |
seizures
acute onset of fever altered mental status focal neurological deficits |
| gptkbp:caused_by |
viruses
|
| gptkbp:clinical_trial |
ongoing studies
vaccine trials investigational therapies antiviral studies |
| gptkbp:community_health |
education and awareness
surveillance vector control outbreak management |
| gptkbp:complication |
gptkb:death
neurological damage |
| gptkbp:complications |
gptkb:depression
anxiety social isolation financial burden work disability |
| gptkbp:death |
varies by virus type
can be high in severe cases |
| gptkbp:diagnosis |
gptkb:Fukuda_criteria
gptkb:MRI CT scan clinical evaluation Canadian Consensus Criteria Institute of Medicine criteria |
| gptkbp:epidemiology |
seasonal outbreaks
geographic distribution |
| gptkbp:first_described_by |
1930s
|
| https://www.w3.org/2000/01/rdf-schema#label |
multiple sclerosis
|
| gptkbp:is_common_in |
young adults
middle-aged individuals |
| gptkbp:is_targeted_at |
viral infections
|
| gptkbp:known_as |
gptkb:ME/_CFS
|
| gptkbp:prevalence |
0.2% to 2.6% of the population
|
| gptkbp:prevention |
vaccination
avoiding mosquito exposure |
| gptkbp:public_awareness |
increased in recent years
|
| gptkbp:research_focus |
biomedical research
vaccine development diagnostic methods psychological aspects treatment options pathogenesis |
| gptkbp:risk_factor |
age
weakened immune system |
| gptkbp:symptoms |
fatigue
headache muscle pain sleep disturbances fever confusion seizures joint pain headaches cognitive dysfunction |
| gptkbp:transmission |
mosquito bites
direct contact with infected fluids |
| gptkbp:treatment |
gptkb:immunotherapy
cognitive behavioral therapy supportive care graded exercise therapy |
| gptkbp:bfsParent |
gptkb:National_Institutes_of_Health
|
| gptkbp:bfsLayer |
3
|